For Consumers

FDA Office of Women's Health Update Archive

 The words Women's Health Alert

 

The Office of Women's Health e-Update highlights women's health initiatives, meetings, and regulatory safety information from the U.S. Food and Drug Administration (FDA). The e-Update is disseminated via email to the public.

Current Issue: July 2017

Message from the Director

 
The summer months are an important time to focus on health and safety. Whether you are helping loved ones find information on their medicine, searching for the latest research or looking for general summer safety tips, I encourage you to look to FDA. FDA works to protect women and their families by approving new treatments and staying at the forefront of research on women’s health topics. Communicating about product safety issues also remains our priority. I hope you will continue to use FDA safety and other information to help make informed decisions for you and your family/ community. In this update, you will find news on pregnancy research, a new treatment for sickle cell disease and opportunities to participate in public meetings and training webinars.
 
Marsha Henderson - Assistant Commissioner for Women’s Health
 
****************************************

Women’s Health Highlights

Public Meeting: Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC)
The 21 Century Cures Act established the PRGLAC Task Force to advise the Secretary of HHS regarding gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women.
 
The Task Force will hold a public meeting on August 21 – 22, 2017, from 8:00am to 5:30pm at the National Institutes of Health.
****************************************
OWH-Funded Researcher Receives Teratology Society’s 2017 F. Clarke Fraser New Investigator Award
Dr. Evi Struble, of FDA’s Center for Biologics Evaluation and Research, recently received the Teratology Society’s 2017 F. Clarke Fraser New Investigator Award in recognition of her OWH-supported study to advance knowledge of the safety and efficacy of antibody therapeutics used in the treatment of viral infections during pregnancy. This work has served to demonstrate the suitability of pregnant guinea pigs as pre-clinical models for these studies. Data from this study will provide information that can inform dosing decisions during pregnancy. OWH supports studies such as this one that address the use of FDA-regulated products during pregnancy.
 
****************************************
Tips for Caregivers
Taking care of family and friends is a normal part of every day for many women. Caregiving, while rewarding, can be tough at times. FDA has tips to help women manage the care of loved ones. Read and share tips from our Tips for Caregivers webpage to help women talk with their family members, other caregivers and health care providers. Help us spread the word! Share www.fda.gov/caregivertips on your webpage, social media or in your outreach.
 
****************************************
How to Safely Use Nail Care Products
Love manicures and pedicures, or know someone who does? The cosmetic products you use, along with lamps that dry (or "cure") gel nail polishes and artificial nails, are regulated by the U.S. Food and Drug Administration.
 
***************************************

Extras

FDA approves new treatment for sickle cell disease
The U.S. Food and Drug Administration approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.
 
****************************************
FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy
The U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.
****************************************
FDA Grand Rounds
Tune in to FDA’s Grand Rounds on Thursday, July 13 from 12-1p.m. EDT. Dr. Marc Allard of FDA’s Center for Food Safety and Nutrition will present, “GenomeTrakr: How a Large Network of Sequencing Laboratories is Transforming Food Safety and Public Health.”
****************************************

Meetings

 
Participate in upcoming FDA Public Meetings.
 
July 28, 2017, 8:30 am to 5:00 pm
FDA White Oak Campus, Silver Spring, MD 
 
***************************************
Visit an OWH exhibit booth or presentation at these upcoming conferences.
 
National Association of Hispanic Nurses
July 18 – 21, 2017, Phoenix, AZ
 
Association of American Indian Physicians National Health Conference
July 27 – 30, Shawnee, OK
 
National Black Nurses Association
July 30 – August 4, 2017, Las Vegas, Nevada
 
American Psychological Association
August 3 – 6, 2017, Washington, DC
 

 __________________________________________________________________ 

 

 

 

Contact FDA

301-796-9440
Fax:301-847-8604
Food and Drug Administration Office of Women's Health

10903 New Hampshire Avenue

WO32-2333

Silver Spring, MD 20993

Page Last Updated: 07/13/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English